{"id":2584,"date":"2020-04-22T16:18:13","date_gmt":"2020-04-22T14:18:13","guid":{"rendered":"https:\/\/www.seedcapitalbizkaia.eus\/histocell-participa-en-un-ensayo-clinico-de-terapia-celular-contra-el-covid-19\/"},"modified":"2020-11-19T15:33:41","modified_gmt":"2020-11-19T13:33:41","slug":"histocell-participa-en-un-ensayo-clinico-de-terapia-celular-contra-el-covid-19","status":"publish","type":"post","link":"https:\/\/www.seedcapitalbizkaia.eus\/eu\/histocell-participa-en-un-ensayo-clinico-de-terapia-celular-contra-el-covid-19\/","title":{"rendered":"Histocellek terapia zelularra erabiltzen duen COVID-19aren aurkako entsegu kliniko batean parte hartzen du"},"content":{"rendered":"<p style=\"text-align: left;\"><a href=\"https:\/\/www.histocell.com\/\">Histocell<\/a> enpresak (<a href=\"https:\/\/www.seedcapitalbizkaia.eus\/eu\/\" target=\"_blank\" rel=\"noopener noreferrer\">Seed Capital Bizkaia<\/a> haren parte da), aurki, terapia zelularra baliatuz sortu duten farmakoarekin entsegu kliniko bat abiaraziko du Gurutzetako Ospitalean, COVID-19a pairatu duten 26 gaixoekin; arnasketa arazoak dituzte paziente hauek.<\/p>\n<p style=\"text-align: left;\">Gaixo hauek Arnasketa Distres Akutuaren Sindromea sufritzen dute (gazteleraz SDRA \u2013 S\u00edndrome de Dificultad Respiratoria Aguda) eta COVID-19ak eragin die sindrome hau; paziente guztiek betetzen dituzte entsegu klinikoan parte hartzeko baldintzak. Proba honek pazienteek sufritzen duten arnasketa distresa gaindetzea du helburu, eta era berean, epe ertain-luzera, heriotza-tasa murriztu eta biriketako ehunean eragindako kalteak gutxitzea.<\/p>\n<h3 style=\"text-align: left;\"><strong>Arnasketa Distres Akutuaren Sindromea, konplikazio larriena<\/strong><\/h3>\n<p style=\"text-align: left;\">Egoera larrian ospitalizatuta egon diren pertsonen %40ak baino gehiagok arnasketa distresa garatzen du eta sindrome hau maila moderatu-gogorrean sufritzen duen %50a haren ondorioz hiltzen da. Beraz, datu hauek zera ondorioztatzen dute, Arnasketa Distres Akutuaren Sindromea dela COVID-19ak eragiten duen infekzioaren konplikazio gaiztoena.<\/p>\n<h3 style=\"text-align: left;\"><strong>HC016, garapen lan luze baten emaitza<\/strong><\/h3>\n<p style=\"text-align: left;\">Histocellek urteak daramatza Arnasketa Distres Akutuaren Sindromearentzat terapia zelularraz baliatzen den botika bat garatzen, HC016 deitu dutena; ehun adiposoetatik lortutako zelula ama helduetan oinarrituta dago, hanturazko ingurune latzetan bizirauteko espreski diseinaturikoak. Horregatik, HC016 zelulak bereziki egokiak dira COVID-19a pairatu duten eta arnasketa distresa garatu duten pazienteak tratatzeko.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Histocell enpresak (Seed Capital Bizkaia haren parte da), aurki, terapia zelularra baliatuz sortu duten farmakoarekin entsegu kliniko bat abiaraziko du Gurutzetako Ospitalean, COVID-19a pairatu duten 26 gaixoekin; arnasketa arazoak dituzte paziente hauek.<\/p>\n","protected":false},"author":2,"featured_media":2459,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":["post-2584","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-noticias-eu"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>[:es]Histocell participa en un ensayo cl\u00ednico de terapia celular contra el Covid-19[:]<\/title>\n<meta name=\"description\" content=\"{:eu}Histocell enpresak (Seed Capital Bizkaia haren parte da), aurki, terapia zelularra baliatuz sortu duten farmakoarekin entsegu kliniko bat abiaraziko du Gurutzetako Ospitalean, COVID-19a pairatu duten 26 gaixoekin; arnasketa arazoak dituzte paziente hauek.{:}\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.seedcapitalbizkaia.eus\/eu\/histocell-participa-en-un-ensayo-clinico-de-terapia-celular-contra-el-covid-19\/\" \/>\n<meta property=\"og:locale\" content=\"eu_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"[:es]Histocell participa en un ensayo cl\u00ednico de terapia celular contra el Covid-19[:]\" \/>\n<meta property=\"og:description\" content=\"{:eu}Histocell enpresak (Seed Capital Bizkaia haren parte da), aurki, terapia zelularra baliatuz sortu duten farmakoarekin entsegu kliniko bat abiaraziko du Gurutzetako Ospitalean, COVID-19a pairatu duten 26 gaixoekin; arnasketa arazoak dituzte paziente hauek.{:}\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.seedcapitalbizkaia.eus\/eu\/histocell-participa-en-un-ensayo-clinico-de-terapia-celular-contra-el-covid-19\/\" \/>\n<meta property=\"og:site_name\" content=\"Seed Capital Bizkaia\" \/>\n<meta property=\"article:published_time\" content=\"2020-04-22T14:18:13+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2020-11-19T13:33:41+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.seedcapitalbizkaia.eus\/wp-content\/uploads\/2020\/04\/MG_2979_alta-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1812\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"seed.com\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"seed.com\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.seedcapitalbizkaia.eus\\\/eu\\\/histocell-participa-en-un-ensayo-clinico-de-terapia-celular-contra-el-covid-19\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.seedcapitalbizkaia.eus\\\/eu\\\/histocell-participa-en-un-ensayo-clinico-de-terapia-celular-contra-el-covid-19\\\/\"},\"author\":{\"name\":\"seed.com\",\"@id\":\"https:\\\/\\\/www.seedcapitalbizkaia.eus\\\/#\\\/schema\\\/person\\\/9f7fe51a3f998da35b8377c79e654262\"},\"headline\":\"Histocellek terapia zelularra erabiltzen duen COVID-19aren aurkako entsegu kliniko batean parte hartzen du\",\"datePublished\":\"2020-04-22T14:18:13+00:00\",\"dateModified\":\"2020-11-19T13:33:41+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.seedcapitalbizkaia.eus\\\/eu\\\/histocell-participa-en-un-ensayo-clinico-de-terapia-celular-contra-el-covid-19\\\/\"},\"wordCount\":204,\"image\":{\"@id\":\"https:\\\/\\\/www.seedcapitalbizkaia.eus\\\/eu\\\/histocell-participa-en-un-ensayo-clinico-de-terapia-celular-contra-el-covid-19\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.seedcapitalbizkaia.eus\\\/wp-content\\\/uploads\\\/2020\\\/04\\\/MG_2979_alta-scaled.jpg\",\"articleSection\":[\"Noticias\"],\"inLanguage\":\"eu-ES\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.seedcapitalbizkaia.eus\\\/eu\\\/histocell-participa-en-un-ensayo-clinico-de-terapia-celular-contra-el-covid-19\\\/\",\"url\":\"https:\\\/\\\/www.seedcapitalbizkaia.eus\\\/eu\\\/histocell-participa-en-un-ensayo-clinico-de-terapia-celular-contra-el-covid-19\\\/\",\"name\":\"[:es]Histocell participa en un ensayo cl\u00ednico de terapia celular contra el Covid-19[:]\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.seedcapitalbizkaia.eus\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.seedcapitalbizkaia.eus\\\/eu\\\/histocell-participa-en-un-ensayo-clinico-de-terapia-celular-contra-el-covid-19\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.seedcapitalbizkaia.eus\\\/eu\\\/histocell-participa-en-un-ensayo-clinico-de-terapia-celular-contra-el-covid-19\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.seedcapitalbizkaia.eus\\\/wp-content\\\/uploads\\\/2020\\\/04\\\/MG_2979_alta-scaled.jpg\",\"datePublished\":\"2020-04-22T14:18:13+00:00\",\"dateModified\":\"2020-11-19T13:33:41+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.seedcapitalbizkaia.eus\\\/#\\\/schema\\\/person\\\/9f7fe51a3f998da35b8377c79e654262\"},\"description\":\"{:eu}Histocell enpresak (Seed Capital Bizkaia haren parte da), aurki, terapia zelularra baliatuz sortu duten farmakoarekin entsegu kliniko bat abiaraziko du Gurutzetako Ospitalean, COVID-19a pairatu duten 26 gaixoekin; arnasketa arazoak dituzte paziente hauek.{:}\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.seedcapitalbizkaia.eus\\\/eu\\\/histocell-participa-en-un-ensayo-clinico-de-terapia-celular-contra-el-covid-19\\\/#breadcrumb\"},\"inLanguage\":\"eu-ES\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.seedcapitalbizkaia.eus\\\/eu\\\/histocell-participa-en-un-ensayo-clinico-de-terapia-celular-contra-el-covid-19\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"eu-ES\",\"@id\":\"https:\\\/\\\/www.seedcapitalbizkaia.eus\\\/eu\\\/histocell-participa-en-un-ensayo-clinico-de-terapia-celular-contra-el-covid-19\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.seedcapitalbizkaia.eus\\\/wp-content\\\/uploads\\\/2020\\\/04\\\/MG_2979_alta-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/www.seedcapitalbizkaia.eus\\\/wp-content\\\/uploads\\\/2020\\\/04\\\/MG_2979_alta-scaled.jpg\",\"width\":2560,\"height\":1812,\"caption\":\"Histocell Seed Capital Bizkaia\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.seedcapitalbizkaia.eus\\\/eu\\\/histocell-participa-en-un-ensayo-clinico-de-terapia-celular-contra-el-covid-19\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\\\/\\\/www.seedcapitalbizkaia.eus\\\/eu\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Histocellek terapia zelularra erabiltzen duen COVID-19aren aurkako entsegu kliniko batean parte hartzen du\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.seedcapitalbizkaia.eus\\\/#website\",\"url\":\"https:\\\/\\\/www.seedcapitalbizkaia.eus\\\/\",\"name\":\"Seed Capital Bizkaia\",\"description\":\"Seed Capital Bizkaia\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.seedcapitalbizkaia.eus\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"eu-ES\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.seedcapitalbizkaia.eus\\\/#\\\/schema\\\/person\\\/9f7fe51a3f998da35b8377c79e654262\",\"name\":\"seed.com\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"eu-ES\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/e813a261e33bb1c143e563e6a68768058e36806fb0b8bb3922b87a5100ba1926?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/e813a261e33bb1c143e563e6a68768058e36806fb0b8bb3922b87a5100ba1926?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/e813a261e33bb1c143e563e6a68768058e36806fb0b8bb3922b87a5100ba1926?s=96&d=mm&r=g\",\"caption\":\"seed.com\"},\"url\":\"https:\\\/\\\/www.seedcapitalbizkaia.eus\\\/eu\\\/author\\\/seed-com\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"[:es]Histocell participa en un ensayo cl\u00ednico de terapia celular contra el Covid-19[:]","description":"{:eu}Histocell enpresak (Seed Capital Bizkaia haren parte da), aurki, terapia zelularra baliatuz sortu duten farmakoarekin entsegu kliniko bat abiaraziko du Gurutzetako Ospitalean, COVID-19a pairatu duten 26 gaixoekin; arnasketa arazoak dituzte paziente hauek.{:}","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.seedcapitalbizkaia.eus\/eu\/histocell-participa-en-un-ensayo-clinico-de-terapia-celular-contra-el-covid-19\/","og_locale":"eu_ES","og_type":"article","og_title":"[:es]Histocell participa en un ensayo cl\u00ednico de terapia celular contra el Covid-19[:]","og_description":"{:eu}Histocell enpresak (Seed Capital Bizkaia haren parte da), aurki, terapia zelularra baliatuz sortu duten farmakoarekin entsegu kliniko bat abiaraziko du Gurutzetako Ospitalean, COVID-19a pairatu duten 26 gaixoekin; arnasketa arazoak dituzte paziente hauek.{:}","og_url":"https:\/\/www.seedcapitalbizkaia.eus\/eu\/histocell-participa-en-un-ensayo-clinico-de-terapia-celular-contra-el-covid-19\/","og_site_name":"Seed Capital Bizkaia","article_published_time":"2020-04-22T14:18:13+00:00","article_modified_time":"2020-11-19T13:33:41+00:00","og_image":[{"width":2560,"height":1812,"url":"https:\/\/www.seedcapitalbizkaia.eus\/wp-content\/uploads\/2020\/04\/MG_2979_alta-scaled.jpg","type":"image\/jpeg"}],"author":"seed.com","twitter_card":"summary_large_image","twitter_misc":{"Written by":"seed.com","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.seedcapitalbizkaia.eus\/eu\/histocell-participa-en-un-ensayo-clinico-de-terapia-celular-contra-el-covid-19\/#article","isPartOf":{"@id":"https:\/\/www.seedcapitalbizkaia.eus\/eu\/histocell-participa-en-un-ensayo-clinico-de-terapia-celular-contra-el-covid-19\/"},"author":{"name":"seed.com","@id":"https:\/\/www.seedcapitalbizkaia.eus\/#\/schema\/person\/9f7fe51a3f998da35b8377c79e654262"},"headline":"Histocellek terapia zelularra erabiltzen duen COVID-19aren aurkako entsegu kliniko batean parte hartzen du","datePublished":"2020-04-22T14:18:13+00:00","dateModified":"2020-11-19T13:33:41+00:00","mainEntityOfPage":{"@id":"https:\/\/www.seedcapitalbizkaia.eus\/eu\/histocell-participa-en-un-ensayo-clinico-de-terapia-celular-contra-el-covid-19\/"},"wordCount":204,"image":{"@id":"https:\/\/www.seedcapitalbizkaia.eus\/eu\/histocell-participa-en-un-ensayo-clinico-de-terapia-celular-contra-el-covid-19\/#primaryimage"},"thumbnailUrl":"https:\/\/www.seedcapitalbizkaia.eus\/wp-content\/uploads\/2020\/04\/MG_2979_alta-scaled.jpg","articleSection":["Noticias"],"inLanguage":"eu-ES"},{"@type":"WebPage","@id":"https:\/\/www.seedcapitalbizkaia.eus\/eu\/histocell-participa-en-un-ensayo-clinico-de-terapia-celular-contra-el-covid-19\/","url":"https:\/\/www.seedcapitalbizkaia.eus\/eu\/histocell-participa-en-un-ensayo-clinico-de-terapia-celular-contra-el-covid-19\/","name":"[:es]Histocell participa en un ensayo cl\u00ednico de terapia celular contra el Covid-19[:]","isPartOf":{"@id":"https:\/\/www.seedcapitalbizkaia.eus\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.seedcapitalbizkaia.eus\/eu\/histocell-participa-en-un-ensayo-clinico-de-terapia-celular-contra-el-covid-19\/#primaryimage"},"image":{"@id":"https:\/\/www.seedcapitalbizkaia.eus\/eu\/histocell-participa-en-un-ensayo-clinico-de-terapia-celular-contra-el-covid-19\/#primaryimage"},"thumbnailUrl":"https:\/\/www.seedcapitalbizkaia.eus\/wp-content\/uploads\/2020\/04\/MG_2979_alta-scaled.jpg","datePublished":"2020-04-22T14:18:13+00:00","dateModified":"2020-11-19T13:33:41+00:00","author":{"@id":"https:\/\/www.seedcapitalbizkaia.eus\/#\/schema\/person\/9f7fe51a3f998da35b8377c79e654262"},"description":"{:eu}Histocell enpresak (Seed Capital Bizkaia haren parte da), aurki, terapia zelularra baliatuz sortu duten farmakoarekin entsegu kliniko bat abiaraziko du Gurutzetako Ospitalean, COVID-19a pairatu duten 26 gaixoekin; arnasketa arazoak dituzte paziente hauek.{:}","breadcrumb":{"@id":"https:\/\/www.seedcapitalbizkaia.eus\/eu\/histocell-participa-en-un-ensayo-clinico-de-terapia-celular-contra-el-covid-19\/#breadcrumb"},"inLanguage":"eu-ES","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.seedcapitalbizkaia.eus\/eu\/histocell-participa-en-un-ensayo-clinico-de-terapia-celular-contra-el-covid-19\/"]}]},{"@type":"ImageObject","inLanguage":"eu-ES","@id":"https:\/\/www.seedcapitalbizkaia.eus\/eu\/histocell-participa-en-un-ensayo-clinico-de-terapia-celular-contra-el-covid-19\/#primaryimage","url":"https:\/\/www.seedcapitalbizkaia.eus\/wp-content\/uploads\/2020\/04\/MG_2979_alta-scaled.jpg","contentUrl":"https:\/\/www.seedcapitalbizkaia.eus\/wp-content\/uploads\/2020\/04\/MG_2979_alta-scaled.jpg","width":2560,"height":1812,"caption":"Histocell Seed Capital Bizkaia"},{"@type":"BreadcrumbList","@id":"https:\/\/www.seedcapitalbizkaia.eus\/eu\/histocell-participa-en-un-ensayo-clinico-de-terapia-celular-contra-el-covid-19\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/www.seedcapitalbizkaia.eus\/eu\/"},{"@type":"ListItem","position":2,"name":"Histocellek terapia zelularra erabiltzen duen COVID-19aren aurkako entsegu kliniko batean parte hartzen du"}]},{"@type":"WebSite","@id":"https:\/\/www.seedcapitalbizkaia.eus\/#website","url":"https:\/\/www.seedcapitalbizkaia.eus\/","name":"Seed Capital Bizkaia","description":"Seed Capital Bizkaia","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.seedcapitalbizkaia.eus\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"eu-ES"},{"@type":"Person","@id":"https:\/\/www.seedcapitalbizkaia.eus\/#\/schema\/person\/9f7fe51a3f998da35b8377c79e654262","name":"seed.com","image":{"@type":"ImageObject","inLanguage":"eu-ES","@id":"https:\/\/secure.gravatar.com\/avatar\/e813a261e33bb1c143e563e6a68768058e36806fb0b8bb3922b87a5100ba1926?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e813a261e33bb1c143e563e6a68768058e36806fb0b8bb3922b87a5100ba1926?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e813a261e33bb1c143e563e6a68768058e36806fb0b8bb3922b87a5100ba1926?s=96&d=mm&r=g","caption":"seed.com"},"url":"https:\/\/www.seedcapitalbizkaia.eus\/eu\/author\/seed-com\/"}]}},"_links":{"self":[{"href":"https:\/\/www.seedcapitalbizkaia.eus\/eu\/wp-json\/wp\/v2\/posts\/2584","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.seedcapitalbizkaia.eus\/eu\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.seedcapitalbizkaia.eus\/eu\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.seedcapitalbizkaia.eus\/eu\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.seedcapitalbizkaia.eus\/eu\/wp-json\/wp\/v2\/comments?post=2584"}],"version-history":[{"count":5,"href":"https:\/\/www.seedcapitalbizkaia.eus\/eu\/wp-json\/wp\/v2\/posts\/2584\/revisions"}],"predecessor-version":[{"id":4622,"href":"https:\/\/www.seedcapitalbizkaia.eus\/eu\/wp-json\/wp\/v2\/posts\/2584\/revisions\/4622"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.seedcapitalbizkaia.eus\/eu\/wp-json\/wp\/v2\/media\/2459"}],"wp:attachment":[{"href":"https:\/\/www.seedcapitalbizkaia.eus\/eu\/wp-json\/wp\/v2\/media?parent=2584"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.seedcapitalbizkaia.eus\/eu\/wp-json\/wp\/v2\/categories?post=2584"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.seedcapitalbizkaia.eus\/eu\/wp-json\/wp\/v2\/tags?post=2584"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}